A 96-well Microfiltration Assay for Measurement of Total Clottable Fibrinogen

Summary

In clinical routine use, fibrinogen is measured by clotting-time methods, or by clot turbidity in photometric prothrombin time determination. For calibration of these assays measurement of total thrombinclottable protein has been recommended. We have now developed a microfiltration assay for total thrombin-clottable protein. Plasma samples were mixed with thrombin in a 96-well microfiltration device. After clot formation, the fluid was extracted by vacuum suction, and fibrin adherent to the filter membranes washed with buffer. Membrane segments with adherent fibrin were recovered from the 96-well manifold with a punch and transferred to tubes containing denaturing buffer solution. After dissolution of fibrin, protein concentration was determined by optical absorption at 280 nm. The microfiltration assay displayed a high correlation with the total clottable protein method (R = 0.95), and fibrinogen antigen (r = 0.96). Correlation with clotting time assays, and PT-derived fibrinogen in 150 clinical plasma samples was in the range of r = 0.84 to r = 0.97. Intraassay and day-to-day variability of the assay was comparable to the conventional total clottable fibrinogen assay. The novel microfiltration assay appears to be well suited for measurement of large series of samples for calibration, screening purposes, and clinical trials.

• References

• 1 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
• 2 Hoffmann JJ, Verhappen MA. Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy. Clin Chem 1988; 34: 2135-40.
• 3 Becker U, Bartl K, Wahlefeld AW. A functional photometric assay for plasma fibrinogen. Thromb Res 1984; 35: 475-84.
• 4 Ratnoff OD, Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med 1951; 10: 316-20.
• 5 Gaffney PJ, Wong MY. Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thromb Haemost 1992; 68: 428-32.
• 6 Rossi E, Mondonico P, Lombardi A, Preda L. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 1988; 52: 453-68.
• 7 Hart R, Bate I, Dinh D, Elms M, Bundesen P, Hillyard C, Rylatt DB. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody. Blood Coagul Fibrinolysis 1994; 5: 227-32.
• 8 Jacobsson K. Studies on the determination of fibrinogen in human blood plasma. Scand J Clin Lab Invest Suppl 1955; 7: 1-54.
• 9 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Ark Kemi 1956; 10: 415-43.
• 10 Palareti G, Maccaferri M, Manotti C, Tripodi A, Chantarangkul V, Rodeghiero F, Ruggeri M, Mannucci PM. Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio. Clin Chem 1991; 37: 714-9.
• 11 Latallo ZS, Fletcher AP, Alkjaersig N, Sherry S. Inhibition of fibrin polymerization by fibrinogen proteolysis products. Am J Physiol 1962; 202: 681-6.
• 12 Varadi A, Scheraga HA. Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen. Biochemistry 1986; 25: 519-28.
• 13 Hoffman M, Greenberg CS. The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen. Am J Clin Pathol 1987; 88: 490-3.